BusinessArbutus Announces Closing of $50 Million First Tranche of $116.4 Million Strategic Investment from Roivant SciencesBy Nasdaq OMXOct 16, 2017, 2:30 PM UTC
BusinessBioAegis Therapeutics Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase 2 Clinical Trials in Community-Acquired PneumoniaBy Nasdaq OMXOct 13, 2017, 2:00 PM UTC
BusinessCytoDyn Provides Update on PRO 140 Combination Therapy Pivotal Trial in HIV Patients Following Constructive Meeting With FDABy Nasdaq OMXOct 13, 2017, 10:00 AM UTC
BusinessHistogenics Corporation Promotes Stephen Kennedy to Executive Vice President & Chief Operating OfficerBy Nasdaq OMXOct 12, 2017, 1:00 PM UTC
BusinessExosome Diagnostics to Present a Novel Atlas of Exosomal mRNA and Long non-coding RNA Across Biofluids at American Society of Exosomes and Microvesicles Annual MeetingBy Nasdaq OMXOct 11, 2017, 11:30 AM UTC
BusinessMenlo Ventures adds Greg Yap as Partner to Focus on Life Science Technology InvestingBy Nasdaq OMXOct 10, 2017, 2:00 PM UTC
